908 Devices Inc.
MASS Nasdaq· Laboratory Analytical Instruments
Last close · Oct 26, 2026
$11.65
KIRA · Stoqly’s AI analyst, in plain words
- 908 Devices Inc. had $56.2M of revenue in fiscal 2025, up 17.7% on the year before. Over five years, revenue changed +15.9% a year on average.
- Its operating margin was −70.1%, up 50.1 pts: of every 100 in sales, about −70 is left after running the business.
- 908 Devices Inc. made $19.5M of net profit in fiscal 2025.
- Free cash flow was −$24.6M in fiscal 2025, −43.9% of revenue.
Market cap
$440M
P/E
—
Revenue
$56.2M
Net income
$19.5M
Free cash flow
−$24.6M
Operating margin
−70.1%
908 Devices Inc. in 30 seconds · fiscal 2025
Are sales growing?
+17.7%
Yes. Sales grew 17.7% last year.
Does it make a profit?
34.7%
Yes. It keeps 34.7% of every sale as profit.
Does profit turn into cash?
−43.9%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 8
Weak. It passes 3 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What 908 Devices Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Mar 9, 2026
- Legal name
- 908 Devices Inc.
- CIK
- 0001555279
908 Devices Inc. · MASS
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $42.2M | $46.9M | $50.2M | $47.7M | $56.2M |
| Revenue growth | 56.9% | 11.0% | 7.2% | −4.9% | 17.7% |
| Gross margin | 55.0% | 55.5% | 50.4% | 51.3% | 50.6% |
| Operating margin | −52.3% | −75.5% | −85.1% | −120.2% | −70.1% |
| Net income | −$22.2M | −$33.6M | −$36.4M | −$72.2M | $19.5M |
| Net margin | −52.5% | −71.6% | −72.5% | −151.2% | 34.7% |
| Diluted EPS | −$0.79 | −$1.07 | −$1.13 | −$2.12 | $0.54 |
| Cash | |||||
| Cash from operations | −$29.1M | −$20.9M | −$25.1M | −$30.2M | −$23.7M |
| Capital expenditure | $0.7M | $2.0M | $2.0M | $0.6M | $1.0M |
| Free cash flow | −$29.8M | −$23.0M | −$27.1M | −$30.8M | −$24.6M |
| FCF margin | −70.7% | −49.0% | −54.0% | −64.6% | −43.9% |
| Share count change | 409.7% | 12.6% | 2.4% | 5.7% | 5.3% |
| Debt and strength | |||||
| Cash and short-term investments | $224M | $188M | $146M | $69.6M | $113M |
| Debt incl. finance leases | $15.0M | $15.0M | — | — | — |
| Shareholders' equity | $215M | $191M | $165M | $115M | $144M |
| Current ratio | 17.0x | 11.2x | 7.7x | 4.1x | 4.2x |
| Interest coverage | −45.4x | −274.3x | −212.7x | — | — |
| Returns and quality | |||||
| Return on capital | −315.2% | −162.7% | — | — | — |
| Return on equity | −12.5% | −16.6% | −20.4% | −51.6% | 15.1% |
| Return on tangible equity | −10.3% | −19.5% | −24.7% | −95.1% | 18.2% |
| Piotroski F-score | 3 | 3 | 2 | 3 | 3 |
| Altman Z'' | 9.0 | 6.4 | 5.4 | −1.5 | 1.8 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$10.0M
6 insiders
Of sales under plans
52%
$5.2M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
908 Devices Inc. · MASS
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $11.65 a share, the company is worth $440M.
Source: SEC EDGAR XBRL filings (CIK 0001555279). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.